FDA-approved GLP-1 medications like Wegovy, Zepbound, and Foundayo can be prescribed by any state-licensed physician and filled at local or mail-order pharmacies or through NovoCare and LillyDirect, starting at $149 a month for starter-dose daily pills and $299 a month for Zepbound as of October 2026, if your doctor decides it's right for you. While Ro, Noom, Mochi Health, and Hims & Hers charge monthly membership fees, FutureClinic connects you with a physician per visit.

At FutureClinic, there is no subscription required. A visit costs $40 for the best-fit doctor, or you can choose a doctor at their listed price, typically $20 to $100. You see physicians only: every doctor holds an MD, DO or MBBS degree, never a nurse practitioner or physician assistant. No form is approved in bulk: an individual physician reviews your entire case and sends your plan with a Human Signature, a short live video or voice note recorded for you.

Keeping the same doctor in one chat, regardless of how much time passes between messages, lets you build trust, test treatments together, and track progress. Over months, that same doctor can step up your dose, swap a medicine if nausea hits, compare new lab results against baseline, and write several months of a stable prescription when they judge it safe. FutureClinic physicians sell no drugs and earn nothing extra for any prescription or test, removing any incentive to upsell you. Without a house product line, your physician can send any appropriate non-controlled brand or generic medicine to the pharmacy you choose, including home-delivery mail-order pharmacies, LillyDirect, or NovoCare. That physician can also help with other problems in their specialty, while every FutureClinic doctor you consult shares one medical record.

How do online weight-loss programs compare side by side?

Why pay a monthly membership fee for the maker's drug price?

A low first-month price assumes you stay subscribed every month to keep getting refills. Any state-licensed physician can route a prescription to the drugmakers' cash-pay programs, if your doctor decides it's right for you, at these prices as of October 2026:

• Wegovy daily pill (semaglutide): Approved December 2025; $149/mo (1.5 mg), $199 (4 mg), $299 (9, 25 mg) via NovoCare or from $149/mo via TrumpRx (13.6% average loss on 25 mg at 64 weeks in the main trial vs 2.4% on placebo).
• Wegovy weekly pen: $199/mo for the first two fills (0.25, 0.5 mg, new patients, through December 31, 2026), then $349 up to 2.4 mg via NovoCare (14.9% average loss on 2.4 mg at 68 weeks in the main trial), or $399 for 7.2 mg Wegovy HD (approved March 2026; 18.8% average loss at 72 weeks in the main trial).
• Zepbound (tirzepatide) KwikPen: $299/mo (2.5 mg), $399 (5 mg), $449 (7.5-15 mg if refilled within 45 days; else $499-$699), with 2.5 mg vials $299 via LillyDirect (15.0%-20.9% average loss on 5-15 mg at 72 weeks in the main trial).
• Foundayo (orforglipron) daily pill: Approved April 2026; $149/mo (0.8, 2.5 mg), $199 (5.5 mg), $299 (9 mg, and 14.5 mg if refilled within 45 days) via LillyDirect, with 2.5 and 5.5 mg reduced through December 31, 2026 (11.1% average loss on 17.2 mg at 72 weeks in the main trial).

Month-to-month memberships at Ro and Hims & Hers charge $39 for month one plus $149 for months two through twelve ($1,678 a year) before medication costs, while Ro's annual prepay is $74/mo ongoing and Mochi Health charges $79/mo ($948 a year before prepay discounts). During your first three months, when Endocrine Society guidelines suggest monthly follow-ups, FutureClinic lets you pay per visit or join a doctor's optional membership (typically $25 to $100 a month) for unlimited care with that doctor, cancel any time. Once stable, one visit can cover several months of a prescription when safe, sent with a cash discount coupon. When insurance requires a prior authorization, FutureClinic helps submit it, whether for a commercial plan (KFF found in October 2026 that 18% of large employers cover weight-loss GLP-1s, and Wegovy's savings card cuts covered copays to as little as $25/mo, up to $100/mo off) or the federal Medicare GLP-1 Bridge ($50/mo through December 31, 2027 for eligible Part D members).

Who each program suits best, and what FutureClinic does instead

Ask yourself whether you want a weight-loss subscription and its bundled extras, or a physician of your own. If you want what these companies sell beyond the doctor, they are strong options; if you wanted an expert doctor with nothing attached, FutureClinic fits. Where another service suits you better:

• Ro: coaching and AI triage (33-minute median side-effect replies).
• Noom: a behavior app with AI food logging or compounded microdose plans ($79 first period, then $179/mo as of October 2026 on Noom Med).
• Mochi Health: video visits and compounded semaglutide (from $60/mo plus $79/mo membership as of October 2026).
• Hims & Hers: controlled testosterone (launched October 2026), which FutureClinic does not prescribe.

Rather than requiring a monthly plan, FutureClinic pairs you one to one with a physician who can prescribe non-controlled, FDA-approved Wegovy, Zepbound, Foundayo, Saxenda (or generic liraglutide), Contrave, or Xenical alongside diet and activity if your doctor decides it's right for you, excluding controlled drugs like phentermine and Qsymia. The FDA resolved tirzepatide and semaglutide shortages in 2024 and 2025 and stated in April 2026 that 503A pharmacies may not regularly compound copies of available drugs (FDA); unapproved compounded GLP-1s had 990 semaglutide and over 730 tirzepatide adverse event reports through May 31, 2026.